Signal transduction by wild-type and leukemogenic Abl proteins - PubMed (original) (raw)

Review

Signal transduction by wild-type and leukemogenic Abl proteins

A B Raitano et al. Biochim Biophys Acta. 1997.

No abstract available

PubMed Disclaimer

Similar articles

• Biology of chronic myelogenous leukemia.
  Verfaillie CM. Verfaillie CM. Hematol Oncol Clin North Am. 1998 Feb;12(1):1-29. doi: 10.1016/s0889-8588(05)70495-0. Hematol Oncol Clin North Am. 1998. PMID: 9523224 Review.
• Molecular biology of chronic myeloid leukemia.
  Maru Y. Maru Y. Int J Hematol. 2001 Apr;73(3):308-22. doi: 10.1007/BF02981955. Int J Hematol. 2001. PMID: 11345196 Review.
• [The Philadelphia chromosome: from the gene to therapeutic methods].
  Pérez-Losada J, González-Sarmiento R, Sánchez-García I. Pérez-Losada J, et al. Sangre (Barc). 1998 Apr;43(2):127-35. Sangre (Barc). 1998. PMID: 9656774 Review. Spanish. No abstract available.
• The proto-oncogene product p120CBL and the adaptor proteins CRKL and c-CRK link c-ABL, p190BCR/ABL and p210BCR/ABL to the phosphatidylinositol-3' kinase pathway.
  Sattler M, Salgia R, Okuda K, Uemura N, Durstin MA, Pisick E, Xu G, Li JL, Prasad KV, Griffin JD. Sattler M, et al. Oncogene. 1996 Feb 15;12(4):839-46. Oncogene. 1996. PMID: 8632906
• Constitutive activation of STAT5 by the BCR-ABL oncogene in chronic myelogenous leukemia.
  Shuai K, Halpern J, ten Hoeve J, Rao X, Sawyers CL. Shuai K, et al. Oncogene. 1996 Jul 18;13(2):247-54. Oncogene. 1996. PMID: 8710363

Cited by

• BCR-ABL1 Tyrosine Kinase Complex Signaling Transduction: Challenges to Overcome Resistance in Chronic Myeloid Leukemia.
  Amarante-Mendes GP, Rana A, Datoguia TS, Hamerschlak N, Brumatti G. Amarante-Mendes GP, et al. Pharmaceutics. 2022 Jan 17;14(1):215. doi: 10.3390/pharmaceutics14010215. Pharmaceutics. 2022. PMID: 35057108 Free PMC article. Review.
• Crk Adaptor Proteins Regulate NK Cell Expansion and Differentiation during Mouse Cytomegalovirus Infection.
  Nabekura T, Chen Z, Schroeder C, Park T, Vivier E, Lanier LL, Liu D. Nabekura T, et al. J Immunol. 2018 May 15;200(10):3420-3428. doi: 10.4049/jimmunol.1701639. Epub 2018 Apr 4. J Immunol. 2018. PMID: 29618525 Free PMC article.
• Two-state dynamics of the SH3-SH2 tandem of Abl kinase and the allosteric role of the N-cap.
  Corbi-Verge C, Marinelli F, Zafra-Ruano A, Ruiz-Sanz J, Luque I, Faraldo-Gómez JD. Corbi-Verge C, et al. Proc Natl Acad Sci U S A. 2013 Sep 3;110(36):E3372-80. doi: 10.1073/pnas.1303966110. Epub 2013 Aug 19. Proc Natl Acad Sci U S A. 2013. PMID: 23959873 Free PMC article.
• Expression of a Src family kinase in chronic myelogenous leukemia cells induces resistance to imatinib in a kinase-dependent manner.
  Pene-Dumitrescu T, Smithgall TE. Pene-Dumitrescu T, et al. J Biol Chem. 2010 Jul 9;285(28):21446-57. doi: 10.1074/jbc.M109.090043. Epub 2010 May 7. J Biol Chem. 2010. PMID: 20452982 Free PMC article.
• A BCR-ABL mutant lacking direct binding sites for the GRB2, CBL and CRKL adapter proteins fails to induce leukemia in mice.
  Johnson KJ, Griswold IJ, O'Hare T, Corbin AS, Loriaux M, Deininger MW, Druker BJ. Johnson KJ, et al. PLoS One. 2009 Oct 13;4(10):e7439. doi: 10.1371/journal.pone.0007439. PLoS One. 2009. PMID: 19823681 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Elsevier Science

• Other Literature Sources

  • The Lens - Patent Citations

• Medical

  • MedlinePlus Health Information

• Molecular Biology Databases

  • Mouse Genome Informatics (MGI)

• Research Materials

  • NCI CPTC Antibody Characterization Program

• Miscellaneous

  • NCI CPTAC Assay Portal